Gilberto Lima Lopes

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

G. Otterson, R. Chiari, J. Sugisaka, 2020, Cancer Immunology and Immunotherapy.

PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data.

P. Hall, P. Aguiar, R. D. De Mello, 2017, Immunotherapy.